What they were paid
Dyne Therapeutics Director Compensation Table · all 2 fiscal years held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $52,500 | $0 | $264,506 | $0 | $317,006 |
| FY2024 | $45,000 | $0 | $501,848 | $0 | $546,848 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Dyne Therapeutics, Inc. DEF 14A filed April 23, 2026, accession 0001193125-26-173655, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025Dyne Therapeutics pays directors a $45,000 cash retainer and $264,506 in equity.
Committees
FY2025 · as the proxy prints themCompensation
The rest of the Dyne Therapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Brian S. Posner | Independent Director | $571,159 |
| Carlo Incerti, M.D | Independent Director | $317,006 |
| Catherine Stehman-Breen, M.D | Independent Director | $327,006 |
| David Lubner | Independent Director | $334,506 |
| Dirk Kersten | Independent Director | $334,506 |
| Jason Rhodes | Chair of the Board | $354,506 |
| John G. Cox | Director | $0 |
| Vikram Karnani | Independent Director | $798,986 |
The full Dyne Therapeutics compensation record
free company briefThis page is one director within Dyne Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat